Literature DB >> 3943160

Echocardiographic assessment of the evolution of amyloid heart disease: a study with familial amyloid polyneuropathy.

M Hongo, S Ikeda.   

Abstract

To determine the evolution of amyloid heart disease, 28 patients with familial amyloid polyneuropathy (FAP) were studied by echocardiography. The incidence and degree of the abnormalities were correlated with the neurologic disabilities, duration of the illness, and age in cross-sectional studies. Serial studies were performed in 12 patients, who were followed for a mean of 27.7 months. At the initial examinations, left ventricular diastolic function was reduced in six patients, while systolic function was preserved in eight. On follow-up there occurred significant increases in ventricular septal wall thickness (from 10.7 +/- 3.1 to 13.1 +/- 3.2 mm; p less than .01) and posterior wall thickness (from 11.8 +/- 2.5 to 13.5 +/- 2.3 mm; p less than .01), and reductions in the E-F slope of the mitral valve (from 64.4 +/- 18.8 to 43.9 +/- 11.0 mm/sec; p less than .01), percent fractional shortening (from 36.5 +/- 9.4% to 28.8 +/- 8.2%; p less than .02), and left ventricular internal diastolic dimension (from 46.2 +/- 6.1 to 42.4 +/- 6.2 mm; p less than .001). At the final examinations, marked ventricular hypertrophy was found in three patients, reduced left ventricular diastolic function in all, impaired systolic function in nine, and decreased left ventricular internal dimension in three. In addition, highly refractile myocardial echoes had appeared in two patients, pericardial effusion in three, and valve thickening in two. We conclude that amyloid heart disease in patients with FAP develops slowly but progressively.

Entities:  

Mesh:

Year:  1986        PMID: 3943160     DOI: 10.1161/01.cir.73.2.249

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

1.  Long term results of heart transplantation in patients with amyloid heart disease.

Authors:  S W Dubrey; M M Burke; A Khaghani; P N Hawkins; M H Yacoub; N R Banner
Journal:  Heart       Date:  2001-02       Impact factor: 5.994

2.  Phase 2 trial of daily, oral epigallocatechin gallate in patients with light-chain amyloidosis.

Authors:  Sohsuke Meshitsuka; Sumito Shingaki; Masatoshi Hotta; Miku Goto; Makoto Kobayashi; Yuuichi Ukawa; Yuko M Sagesaka; Yasuyo Wada; Masanori Nojima; Kenshi Suzuki
Journal:  Int J Hematol       Date:  2016-11-04       Impact factor: 2.490

3.  Effects of the main green tea polyphenol epigallocatechin-3-gallate on cardiac involvement in patients with AL amyloidosis.

Authors:  Derliz Mereles; Sebastian J Buss; Stefan E Hardt; Werner Hunstein; Hugo A Katus
Journal:  Clin Res Cardiol       Date:  2010-03-10       Impact factor: 5.460

4.  Magnetic Resonance Imaging in Cardiac Amyloidosis: Unraveling the Stealth Entity.

Authors:  Omair Shah; Naseer Choh; Tahleel Shera; Faiz Shera; Tariq Gojwari; Feroze Shaheen; Irfan Robbani
Journal:  Int J Angiol       Date:  2021-09-21

5.  A patient with cardiac amyloidosis presenting a rapid increase in technetium-99m-hydroxymethylene diphosphonate accumulation.

Authors:  T Kobayashi; M Sekiya; Y Fujiwara; T Sumimoto; H Matsuoka; M Hamada; K Hiwada
Journal:  Ann Nucl Med       Date:  1993-11       Impact factor: 2.668

6.  Impaired left ventricular diastolic filling in patients with familial amyloid polyneuropathy: a pulsed Doppler echocardiographic study.

Authors:  O Kinoshita; M Hongo; H Yamada; T Misawa; J Kono; S Okubo; S Ikeda
Journal:  Br Heart J       Date:  1989-02

Review 7.  Deposit Diseases as Differential Diagnosis of Left Ventricular Hypertrophy in Patients with Heart Failure and Preserved Systolic Function.

Authors:  Fábio Fernandes; Murillo Oliveira Antunes; Viviane Tiemi Hotta; Carlos Eduardo Rochitte; Charles Mady
Journal:  Arq Bras Cardiol       Date:  2019-11       Impact factor: 2.000

8.  Clinical, Laboratory, and Imaging Profile in Patients with Systemic Amyloidosis in a Brazilian Cardiology Referral Center.

Authors:  Fábio Fernandes; Aristóteles Comte de Alencar Neto; Bruno Vaz Kerges Bueno; Caio Rebouças Fonseca Cafezeiro; João Henrique Rissato; Roberta Shcolnik Szor; Mariana Lombardi Peres de Carvalho; Wilson Mathias Júnior; Angelina Maria Martins Lino; Jussara Bianchi Castelli; Evandro de Oliveira Souza; Félix José Alvarez Ramires; Viviane Tiemi Hotta; José Soares Júnior; Caio de Assis Moura Tavares; José Eduardo Krieger; Carlos Eduardo Rochitte; André Dabarian; Ludhmila Abrahão Hajjar; Roberto Kalil Filho; Charles Mady
Journal:  Arq Bras Cardiol       Date:  2022-02       Impact factor: 2.000

9.  A case of cardiac dysfunction associated with monoclonal gammopathy of undetermined significance.

Authors:  Suk-Tae Jang; Il-Suk Sohn; Eun-Sun Jin; Jin-Man Cho; Chong-Jin Kim; Sung-Jig Lim
Journal:  J Korean Med Sci       Date:  2009-04-20       Impact factor: 2.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.